Advertisement
ResearchIn-Press PreviewAutoimmunityImmunology
Open Access | 10.1172/JCI183671
1Immunobiology and Transplant Science Center and Department of Surgery, Houston Methodist Hospital, Texas Medical Center, Houston, United States of America
Find articles by
Xiao, X.
in:
JCI
|
PubMed
|
Google Scholar
|
1Immunobiology and Transplant Science Center and Department of Surgery, Houston Methodist Hospital, Texas Medical Center, Houston, United States of America
Find articles by Du, Y. in: JCI | PubMed | Google Scholar
1Immunobiology and Transplant Science Center and Department of Surgery, Houston Methodist Hospital, Texas Medical Center, Houston, United States of America
Find articles by Sun, S. in: JCI | PubMed | Google Scholar
1Immunobiology and Transplant Science Center and Department of Surgery, Houston Methodist Hospital, Texas Medical Center, Houston, United States of America
Find articles by Su, X. in: JCI | PubMed | Google Scholar
1Immunobiology and Transplant Science Center and Department of Surgery, Houston Methodist Hospital, Texas Medical Center, Houston, United States of America
Find articles by
Xing, J.
in:
JCI
|
PubMed
|
Google Scholar
|
1Immunobiology and Transplant Science Center and Department of Surgery, Houston Methodist Hospital, Texas Medical Center, Houston, United States of America
Find articles by Wang, G. in: JCI | PubMed | Google Scholar
1Immunobiology and Transplant Science Center and Department of Surgery, Houston Methodist Hospital, Texas Medical Center, Houston, United States of America
Find articles by Elzein, S. in: JCI | PubMed | Google Scholar
1Immunobiology and Transplant Science Center and Department of Surgery, Houston Methodist Hospital, Texas Medical Center, Houston, United States of America
Find articles by Zou, D. in: JCI | PubMed | Google Scholar
1Immunobiology and Transplant Science Center and Department of Surgery, Houston Methodist Hospital, Texas Medical Center, Houston, United States of America
Find articles by Minze, L. in: JCI | PubMed | Google Scholar
1Immunobiology and Transplant Science Center and Department of Surgery, Houston Methodist Hospital, Texas Medical Center, Houston, United States of America
Find articles by Mao, Z. in: JCI | PubMed | Google Scholar
1Immunobiology and Transplant Science Center and Department of Surgery, Houston Methodist Hospital, Texas Medical Center, Houston, United States of America
Find articles by Ghobrial, R. in: JCI | PubMed | Google Scholar
1Immunobiology and Transplant Science Center and Department of Surgery, Houston Methodist Hospital, Texas Medical Center, Houston, United States of America
Find articles by Connor, A. in: JCI | PubMed | Google Scholar
1Immunobiology and Transplant Science Center and Department of Surgery, Houston Methodist Hospital, Texas Medical Center, Houston, United States of America
Find articles by Chen, W. in: JCI | PubMed | Google Scholar
1Immunobiology and Transplant Science Center and Department of Surgery, Houston Methodist Hospital, Texas Medical Center, Houston, United States of America
Find articles by Zhang, Z. in: JCI | PubMed | Google Scholar
1Immunobiology and Transplant Science Center and Department of Surgery, Houston Methodist Hospital, Texas Medical Center, Houston, United States of America
Find articles by
Li, X.
in:
JCI
|
PubMed
|
Google Scholar
|
Published December 31, 2024 - More info
T cells have a remarkable capacity to clonally expand, a process that is intricately linked to their effector activities. As vigorously proliferating T cell also incur substantial DNA lesions, how the dividing T cells safeguard their genomic integrity to allow the generation of T effector cells remains largely unknown. Here we report the identification of the apurinic/apyrimidinic endonuclease-1 (Apex1) as an indispensable molecule for the induction of cytopathic T effectors in mouse models. We demonstrate that conditional deletion of Apex1 in T cells results in a remarkable accumulation of baseless DNA sites in the genome of proliferating T cells, which further leads to genomic instability and apoptotic cell death. Consequently, Apex1-deleted T cells fail to acquire any effector features after activation and fail to mediate autoimmune diseases and allergic tissue damages. Detailed mutational analyses pinpoint the importance of its endonuclease domain in the generation of T effector cells. We provide further evidence that inhibiting the base repair activities of Apex1 with chemical inhibitors similarly abrogates the induction of autoimmune diseases. Collectively, our study suggests that Apex1 serves as a gatekeeper for the generation of cytopathic T cells and that therapeutically targeting Apex1 may have important clinical implications in the treatment of autoimmune diseases.